Voriconazole Patent Expiration

Voriconazole is used for treating fungal infections. It was first introduced by Pf Prism Cv in its drug Vfend on May 24, 2002. Another drug containing Voriconazole is Voriconazole. 25 different companies have introduced drugs containing Voriconazole.


Voriconazole Patents

Given below is the list of patents protecting Voriconazole, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vfend US6632803 Pharmaceutical formulations containing voriconazole Jun 02, 2018

(Expired)

Pf Prism Cv
Vfend US5567817 Triazole antifungal agents May 24, 2016

(Expired)

Pf Prism Cv



Voriconazole's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Voriconazole Generic API Manufacturers

Several generic applications have been filed for Voriconazole. The first generic version for Voriconazole was by Mylan Pharmaceuticals Inc and was approved on Apr 22, 2010. And the latest generic version is by Aspiro Pharma Ltd and was approved on Apr 3, 2024.

Given below is the list of companies who have filed for Voriconazole generic, along with the locations of their manufacturing plants worldwide.